Filing Details

Accession Number:
0001209191-14-009717
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-12 16:35:11
Reporting Period:
2014-02-10
Filing Date:
2014-02-12
Accepted Time:
2014-02-12 16:35:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1453814 Medidata Solutions Inc. MDSO Services-Prepackaged Software (7372) 522319066
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1466265 Michael Glen Vries De C/O Medidata Solutions, Inc.
350 Hudson Street, 9Th Floor
New York NY 10014
President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-10 18,688 $0.00 991,354 No 4 A Direct
Common Stock Acquisiton 2014-02-10 123,744 $0.00 1,115,098 No 4 A Direct
Common Stock Acquisiton 2014-02-10 61,872 $0.00 1,176,970 No 4 M Direct
Common Stock Disposition 2014-02-11 20,000 $54.40 1,156,970 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 A Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units (Performance-Related) Acquisiton 2014-02-10 18,691 $0.00 18,691 $0.00
Common Stock Restricted Stock Units (Performance-Related) Disposition 2014-02-10 30,936 $0.00 30,936 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,691 No 4 A Direct
0 No 4 M Direct
Footnotes
  1. Award of shares of restricted stock under the issuer's Second Amended & Restated 2009 Long-Term Incentive Plan (the "2009 LTIP") on February 10, 2014. The restrictions will lapse with respect to one-fourth of the shares on each of February 10, 2015, February 10, 2016, February 10, 2017 and February 10, 2018.
  2. Represents restricted stock units earned in connection with a performance-based restricted stock unit ("PBRSU") award on February 14, 2013, based on achievement of certain targets in fiscal year 2013. The restricted stock units were settled at 200% of the target grant amount. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Shares will be issued in settlement of these restricted stock units in equal annual installments on February 14, 2014, February 14, 2015 and February 14, 2016.
  3. Represents restricted stock units earned in connection with a PBRSU award on February 14, 2013, based on achievement of target total stockholder return ("TSR") for 2013 relative to the TSR of companies in the NASDAQ Composite Index for 2013. The restricted stock units were settled at 200% of the target grant amount (the target amount was previously reported in Table II-see footnote 7 below). Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Shares will be issued in settlement of these restricted stock units in equal annual installments on February 14, 2014, February 14, 2015 and February 14, 2016.
  4. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2013.
  5. Such transaction was executed in multiple trades at prices ranging from $53.35 to $55.12. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. Award of PBRSUs under the 2009 LTIP on February 10, 2014. The number of PBRSUs reported represents a target grant amount. Each PBRSU represents a contingent right to receive 0-200% of that target number of shares of the issuer's common stock, based on the issuer's TSR as compared to the TSR of companies in the NASDAQ Composite Index for the year ending December 31, 2014. The actual number of shares that will be issued, if at all, in settlement of the PBRSUs may range from 0% to 200% of the target grant and will vest in equal annual installments on February 10, 2015, February 10, 2016 and February 10, 2017. The reporting person also received additional awarded PBRSUs, all subject to corporate financial performance metrics.
  7. Indicates conversion upon vesting of certain PBRSUs granted on February 14, 2013. The number of shares has been adjusted to reflect the issuer's two-for-one stock split, which became effective on December 16, 2013.